全文获取类型
收费全文 | 1657799篇 |
免费 | 137637篇 |
国内免费 | 2738篇 |
专业分类
耳鼻咽喉 | 22110篇 |
儿科学 | 54518篇 |
妇产科学 | 47232篇 |
基础医学 | 235712篇 |
口腔科学 | 48467篇 |
临床医学 | 147212篇 |
内科学 | 327057篇 |
皮肤病学 | 34923篇 |
神经病学 | 135558篇 |
特种医学 | 66441篇 |
外国民族医学 | 475篇 |
外科学 | 251740篇 |
综合类 | 40426篇 |
现状与发展 | 3篇 |
一般理论 | 600篇 |
预防医学 | 128347篇 |
眼科学 | 37935篇 |
药学 | 125272篇 |
4篇 | |
中国医学 | 3044篇 |
肿瘤学 | 91098篇 |
出版年
2018年 | 16117篇 |
2016年 | 13979篇 |
2015年 | 16317篇 |
2014年 | 22529篇 |
2013年 | 33973篇 |
2012年 | 46763篇 |
2011年 | 49016篇 |
2010年 | 28742篇 |
2009年 | 27472篇 |
2008年 | 46931篇 |
2007年 | 49545篇 |
2006年 | 50327篇 |
2005年 | 48709篇 |
2004年 | 47941篇 |
2003年 | 45765篇 |
2002年 | 44758篇 |
2001年 | 76176篇 |
2000年 | 78670篇 |
1999年 | 66932篇 |
1998年 | 18463篇 |
1997年 | 16943篇 |
1996年 | 16835篇 |
1995年 | 16522篇 |
1994年 | 15469篇 |
1993年 | 14592篇 |
1992年 | 55709篇 |
1991年 | 54022篇 |
1990年 | 52772篇 |
1989年 | 51038篇 |
1988年 | 47424篇 |
1987年 | 46745篇 |
1986年 | 44484篇 |
1985年 | 43034篇 |
1984年 | 32297篇 |
1983年 | 27849篇 |
1982年 | 16480篇 |
1981年 | 14746篇 |
1980年 | 13860篇 |
1979年 | 30624篇 |
1978年 | 21269篇 |
1977年 | 17931篇 |
1976年 | 16810篇 |
1975年 | 17656篇 |
1974年 | 21572篇 |
1973年 | 20739篇 |
1972年 | 18921篇 |
1971年 | 17827篇 |
1970年 | 16338篇 |
1969年 | 15299篇 |
1968年 | 13967篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Zhenzhen Zhang Mark Garzotto Tomasz M. Beer Philippe Thuillier Stephen Lieberman Motomi Mori 《Nutrition and cancer》2016,68(8):1309-1319
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue. 相似文献
52.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
53.
54.
55.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献56.
57.
58.
59.
Mark Koday DDS Stephen Davis DDS Molly Melbye DDS MPH 《Journal of public health dentistry》2020,80(Z2):S114-S116
The Yakima Valley Farm Workers Clinic (YVFWC) is one of the largest community health centers in the country with clinics throughout south-central Washington and northern Oregon. Its dental program consists of 14 dental clinics providing general and specialty services to the low-income populations it serves. Modeling itself after the YVFWC medical managed care program; the Dental program recently added value-based metrics to its dental practice after Oregon offered a value-based dental reimbursement plan in 2019. This is the first-step YVFWC's dental program that has taken to prepare for value-based reimbursement and transform its dental practice in order to reduce the disease burden in its patient population. The purpose of this article is to describe the processes YVFWC undertook to prepare itself for the new reimbursement model, which included the development of metrics, a metric validation process, a clinical dashboard, and a method for improving metrics. It also outlines its medical/dental integration improvement brought about by embedding hygienists into the medical primary care teams. 相似文献